Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127824461 | 12782446 | 1 | I | 201606 | 20160921 | 20160927 | 20160927 | EXP | FR-009507513-1609FRA010308 | MERCK | 56.79 | YR | M | Y | 0.00000 | 20160927 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127824461 | 12782446 | 1 | PS | TEMODAL | TEMOZOLOMIDE | 1 | Oral | 1 DF, 5 IN 1 CYCLE, WITH PROGRESSIVE INCREASE OF DOSAGE | Y | Y | 21029 | 1 | DF | CAPSULE | |||||
127824461 | 12782446 | 2 | SS | TEMODAL | TEMOZOLOMIDE | 1 | Oral | AT A LOW DOSE | Y | Y | 21029 | CAPSULE |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127824461 | 12782446 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127824461 | 12782446 | Blister | |
127824461 | 12782446 | Mucosal inflammation | |
127824461 | 12782446 | Pruritus | |
127824461 | 12782446 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127824461 | 12782446 | 1 | 201603 | 201607 | 0 | |
127824461 | 12782446 | 2 | 201601 | 201602 | 0 |